Detalhe da pesquisa
1.
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.
Cancer
; 122(21): 3327-3335, 2016 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27433944
2.
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma.
Crit Rev Oncol Hematol
; 196: 104289, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38341119
3.
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 17(9): 555-562, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28735890
4.
Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes.
Eur J Cell Biol
; 81(1): 26-35, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11893076